Cancer statistics, 2009

Cited by (1,040)

Items 1,001–1,040 of 1,040

1. Combining support vector machine with genetic algorithm to classify ultrasound breast tumor images
   Wu, Wen-Jie, Lin, Shih-Wei, Moon, Woo Kyung · 2012 · Computerized Medical Imaging and Graphics
2. How to adapt the pulmonary rehabilitation programme to patients with chronic respiratory disease other than COPD
   Holland, Anne E., Wadell, Karin, Spruit, Martijn A. · 2013 · European Respiratory Review
3. Osteosarcoma: Evolution of Treatment Paradigms
   Jaffe, Norman, Puri, Ajay, Gelderblom, Hans · 2013 · Sarcoma
4. MEK1/2 Inhibitors AS703026 and AZD6244 May Be Potential Therapies for <i>KRAS</i> Mutated Colorectal Cancer That Is Resistant to EGFR Monoclonal Antibody Therapy
   Yoon, Juyong, Koo, Kyoung-Hwa, Choi, Kang-Yell · 2011 · Cancer Research
5. Addition of bevacizumab to chemotherapy in advanced non-small cell lung cancer: a systematic review and meta-analysis
   Lima, André Bacellar Costa, Macedo, Ligia T., Sasse, André Deeke · 2011 · PLoS ONE
6. Metabolic Tumor Volume is an Independent Prognostic Factor in Patients Treated Definitively for Non–Small-Cell Lung Cancer
   Lee, Percy, Bazan, Jose G., Lavori, Philip W., Weerasuriya, Dilani K., Quon, Andrew, Le, Quynh-Thu, Wakelee, Heather A., Graves, Edward E., Loo, Billy W. · 2012 · Clinical Lung Cancer
7. Expression of Membrane Progesterone Receptors (mPR/PAQR) in Ovarian Cancer Cells: Implications for Progesterone-Induced Signaling Events
   Charles, Nathan J., Thomas, Peter, Lange, Carol A. · 2010 · Hormones and Cancer
8. Somatic mutation of fibroblast growth factor receptor‐3 ( <i>FGFR3</i> ) defines a distinct morphological subtype of high‐grade urothelial carcinoma
   Al‐Ahmadie, Hikmat A, Iyer, Gopa, Janakiraman, Manickam, Lin, Oscar, Heguy, Adriana, Tickoo, Satish K., Fine, Samson W., Gopalan, Anuradha, Chen, Ying‐bei, Balar, Arjun et al. · 2011 · The Journal of Pathology
9. Opportunities and challenges in combination gene cancer therapy
   Nastiuk, Kent L., Krolewski, John J. · 2016 · Advanced Drug Delivery Reviews
10. RasGRP1 opposes proliferative EGFR–SOS1–Ras signals and restricts intestinal epithelial cell growth
    Depeille, Philippe, Henricks, Linda M., van de Ven, Robert A. H., Lemmens, Ed, Wang, Chih-Yang, Matli, Mary, Werb, Zena, Haigis, Kevin M., Donner, David, Warren, Robert et al. · 2015 · Nature Cell Biology
11. Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: A multicentre, open-label phase I-II study of metformin with erlotinib in second-line therapy of patients with stage IV non-small-cell lung cancer
    Morgillo, Floriana, Fasano, Morena, Della Corte, Carminia Maria, Sasso, Ferdinando Carlo, Papaccio, Federica, Viscardi, Giuseppe, Esposito, Giovanna, Di Liello, Raimondo, Normanno, Nicola, Capuano, Annalisa et al. · 2017 · ESMO Open
12. Drugging K-RasG12C through covalent inhibitors: Mission possible?
    Ni, Duan, Li, Xinyi, He, Xinheng, Zhang, Hao, Zhang, Jian, Lu, Shaoyong · 2019 · Pharmacology &amp; Therapeutics
13. Impacts of Activation of the Mitogen-Activated Protein Kinase Pathway in Pancreatic Cancer
    Furukawa, Toru · 2015 · Frontiers in Oncology
14. Chronic Myeloid Leukemia: Mechanisms of Resistance and Treatment
    Jabbour, Elias, Parikh, Sameer A., Kantarjian, Hagop, Cortes, Jorge · 2011 · Hematology/Oncology Clinics of North America
15. Phase II randomized, double-blind, placebo-controlled study of AMG 386 (trebananib) in combination with cisplatin and capecitabine in patients with metastatic gastro-oesophageal cancer
    Eatock, M.M., Tebbutt, N.C., Bampton, C.L., Strickland, A.H., Valladares-Ayerbes, M., Swieboda-Sadlej, A., Van Cutsem, E., Nanayakkara, N., Sun, Y.-N., Zhong, Z.D. et al. · 2013 · Annals of Oncology
16. Predictors of the Trajectories of Self-Reported Sleep Disturbance in Men with Prostate Cancer During and Following Radiation Therapy
    Miaskowski, Christine, Paul, Steven M., Cooper, Bruce A., Lee, Kathryn, Dodd, Marylin, West, Claudia, Aouizerat, Bradley E., Dunn, Laura, Swift, Patrick S., Wara, William · 2011 · Sleep
17. Marine benthic cyanobacteria contain apoptosis-inducing activity synergizing with daunorubicin to kill leukemia cells, but not cardiomyocytes
    Oftedal, Linn, Selheim, Frode, Wahlsten, Matti, Sivonen, Kaarina, Døskeland, Stein Ove, Herfindal, Lars · 2010 · Marine Drugs
18. Necrosis related HIF-1α expression predicts prognosis in patients with endometrioid endometrial carcinoma
    Seeber, Laura MS, Horrée, Nicole, van der Groep, Petra, van der Wall, Elsken, Verheijen, René HM, van Diest, Paul J · 2010 · BMC Cancer
19. Establishment and characterization of 13 human colorectal carcinoma cell lines: mutations of genes and expressions of drug-sensitivity genes and cancer stem cell markers
    Ku, Ja-Lok, Shin, Young-Kyoung, Kim, Duck-Woo, Kim, Kyung-Hee, Choi, Jin-Sung, Hong, Sung-Hye, Jeon, You-Kyung, Kim, Sung-Hee, Kim, Hong-Sun, Park, Jae-Hyun et al. · 2010 · Carcinogenesis
20. From Despair to Hope: A Longitudinal Study of Illness Perceptions and Coping in a Psycho-Educational Group Intervention for Women with Breast Cancer
    Fischer, Maarten J., Wiesenhaan, Marion E., Heijer, Aukje Does‐den, Kleijn, Wim C., Nortier, Johan W. R., Kaptein, Adrian A. · 2013 · British Journal of Health Psychology
21. Anamorelin for advanced non-small-cell lung cancer with cachexia: Systematic review and meta-analysis
    Nishie, Kenichi, Yamamoto, Shuhei, Nagata, Chie, Koizumi, Tomonobu, Hanaoka, Masayuki · 2017 · Lung Cancer
22. Inhibitors of the PD-1/PD-L1 axis for the treatment of head and neck cancer: Current status and future perspectives
    Ran, Xiongwen, Yang, Kai · 2017 · Drug Design Development and Therapy
23. Biologic correlation between glucose transporters, hexokinase-II, Ki-67 and FDG uptake in malignant melanoma
    Park, Seok Gun, Lee, Jai Hyuen, Lee, Won Ae, Han, Kang Min · 2012 · Nuclear Medicine and Biology
24. The T-box transcription factor, TBX3, is sufficient to promote melanoma formation and invasion
    Peres, Jade, Prince, Sharon · 2013 · Molecular Cancer
25. Inhibition of lung tumor growth by targeting EGFR/VEGFR-Akt/NF-κB pathways with novel theanine derivatives
    Zhang, Guoying, Ye, Xinshan, Ji, Dexin, Zhang, Huarong, Sun, Fujia, Shang, Chunqing, Zhang, Ying, Wu, Erxi, Wang, Fengfei, Wu, Fei et al. · 2014 · Oncotarget
26. Germline Polymorphisms in Genes Involved in the IGF1 Pathway Predict Efficacy of Cetuximab in Wild-type <i>KRAS</i> mCRC Patients
    Winder, Thomas, Zhang, Wu, Yang, Dongyun, Ning, Yan, Bohanes, Pierre, Gerger, Armin, Wilson, Peter M., Pohl, Alexandra, Mauro, David J., Langer, Christiane et al. · 2010 · Clinical Cancer Research
27. The quality of life of Brazilian patients in palliative care: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 15 PAL (EORTC QLQ-C15-PAL)
    Nunes, Natália Abou Hala · 2014 · Supportive Care in Cancer
28. PRIMA-1MET induces apoptosis through accumulation of intracellular reactive oxygen species irrespective of p53 status and chemo-sensitivity in epithelial ovarian cancer cells
    YOSHIKAWA, NOBUHISA, KAJIYAMA, HIROAKI, NAKAMURA, KAE, UTSUMI, FUMI, NIIMI, KAORU, MITSUI, HIROKO, SEKIYA, RYUICHIRO, SUZUKI, SHIRO, SHIBATA, KIYOSUMI, CALLEN, DAVID et al. · 2016 · Oncology Reports
29. Body mass index and the risk of cancer in women compared with men: A meta-analysis of prospective cohort studies
    Xue, Kai, Li, Feng-Feng, Chen, Yi-Wei, Zhou, Yu-Hao, He, Jia · 2017 · European Journal of Cancer Prevention
30. Contrasting effects of the cytotoxic anticancer drug gemcitabine and the EGFR tyrosine kinase inhibitor gefitinib on NK cell-mediated cytotoxicity via regulation of NKG2D ligand in non-small-cell lung cancer cells
    Okita, Riki, Wolf, Diana, Yasuda, Koichiro, Maeda, Ai, Yukawa, Takuro, Saisho, Shinsuke, Shimizu, Katsuhiko, Yamaguchi, Yoshiyuki, Oka, Mikio, Nakayama, Eiichi et al. · 2015 · PLoS ONE
31. Aurora-A/ERK1/2/mTOR axis promotes tumor progression in triple-negative breast cancer and dual-targeting Aurora-A/mTOR shows synthetic lethality
    Zhang, Wenfeng, Xia, Ding, Li, Zhangyun, Zhou, Tao, Chen, Tingting, Wu, Zhengping, Zhou, Weihua, Li, Zilun, Li, Longkun, Xu, Jie · 2019 · Cell Death &amp; Disease
32. Vitamin A Intake and Risk of Melanoma: A Meta-Analysis
    Zhang, Yun-Ping, Chu, Rui-Xue, Liu, Hui · 2014 · PLoS ONE
33. High-Dose Isoflavones Do Not Improve Metabolic and Inflammatory Parameters in Androgen-Deprived Men With Prostate Cancer
    Napora, J. K., Short, R. G., Muller, D. C., Carlson, O. D., Odetunde, J. O., Xu, X., Carducci, M., Travison, T. G., Maggio, M., Egan, J. M. et al. · 2011 · Journal of Andrology
34. Interventions for promoting participation in shared decision-making for children with cancer
    Coyne, Imelda, O'Mathúna, Dónal P, Gibson, Faith, Shields, Linda, Sheaf, Greg · 2013 · Cochrane Database of Systematic Reviews
35. AMPK activation overcomes anti-EGFR antibody resistance induced by KRAS mutation in colorectal cancer
    Ye, Hua, Liu, Yi, Wu, Kefeng, Luo, Hui, Cui, Liao · 2020 · Cell Communication and Signaling
36. Developing Screening Services for Colorectal Cancer on Android Smartphones
    Wu, Hui-Ching, Chang, Chiao-Jung, Lin, Chun-Che, Tsai, Ming-Chang, Chang, Che-Chia, Tseng, Ming-Hseng · 2014 · Telemedicine and e-Health
37. 3D Co-culture System of Tumor-Associated Macrophages and Ovarian Cancer Cells
    Long, Lingli, Yin, Mingzhu, Min, Wang · 2018 · BIO-PROTOCOL
38. Integrated genomic analyses of ovarian carcinoma
    The Cancer Genome Atlas Research Network · 2011 · Nature
39. Sexual health recovery for prostate cancer survivors: the proposed role of acceptance and mindfulness-based interventions
    Bossio, Jennifer A., Miller, Faith, O’Loughlin, Julia I., Brotto, Lori A. · 2019 · Sexual Medicine Reviews
40. Telomerase activity as a marker for differential diagnosis of pancreatic adenocarcinoma: A systematic review and meta-analysis
    Gu, Huajian, Xin, Xiaoyan, Pan, Yaozhen, Zhang, Hong, Tian, She, Sun, Chengyi · 2016 · The International Journal of Biological Markers